Is Progestin-Only Birth Control Better Than Combined?

Neither progestin-only nor combined hormonal birth control is universally better. The answer depends almost entirely on your body, your health history, and what you’re trying to optimize for. Progestin-only methods carry a meaningful safety advantage for people at risk of blood clots and work well during breastfeeding, but combined pills tend to deliver more predictable periods and clearer skin. The research on each trade-off is more nuanced than most online summaries suggest, and some of the conventional wisdom about these two categories has shifted in recent years.

Blood Clot Risk Is the Biggest Safety Difference

The single clearest advantage of progestin-only contraception is its relationship with blood clots. Combined pills contain estrogen, and estrogen promotes clotting. That’s been understood for decades, and it’s the main reason combined methods carry extra cardiovascular warnings. Progestin-only pills, implants, and hormonal IUDs are generally not associated with an increased risk of venous thromboembolism (VTE).¹ The one notable exception is the injectable form, depot medroxyprogesterone acetate (DMPA, often known by the brand name Depo-Provera), which has been linked to higher VTE risk, particularly in people who already have clotting risk factors like diabetes or recent childbirth.²

For anyone with a personal or family history of blood clots, or who has a known clotting disorder, progestin-only pills, implants, and hormonal IUDs are considered the hormonal contraceptives of choice.¹ If you don’t have those risk factors, the absolute risk from combined pills is still quite low for most people of reproductive age. But the relative difference between the two categories on clotting is real and consistent across the literature.

Who Can Actually Use Each Type

Because of the estrogen component, combined hormonal contraceptives come with a longer list of situations where they shouldn’t be used. Under U.S. medical eligibility criteria, conditions like high blood pressure, migraines with aura, and smoking in people 35 or older are contraindications to combined pills but not to progestin-only pills.³ That means progestin-only options are available to a broader population. If you’ve been told you can’t use “the pill” because of a health condition, your provider was likely referring to the combined version, and a progestin-only method may still be on the table.

Combined pills are also not recommended for breastfeeding people in the early postpartum period, or for non-breastfeeding people immediately after delivery, due to elevated clot risk. Progestin-only methods don’t carry those restrictions.⁴ This makes the progestin-only category the default hormonal option for many people in the months after having a baby.

How They Compare on Effectiveness

When it comes to preventing pregnancy, the two categories perform similarly in real-world use, but the details matter. Traditional progestin-only pills (the older norethindrone-type) require stricter timing: they need to be taken within the same three-hour window each day. Combined pills offer a wider margin for late doses. That timing sensitivity is a practical disadvantage that can affect effectiveness for people with unpredictable schedules.

Among progestin-only pills, head-to-head data is limited. A Cochrane review found that desogestrel-containing progestin-only pills were not significantly more effective than levonorgestrel-containing ones, though the trend pointed in desogestrel’s favor.⁵ Desogestrel pills work primarily by suppressing ovulation, while older progestin-only pills rely more on thickening cervical mucus and may not block ovulation consistently. This is a meaningful mechanistic difference that newer formulations try to address.

Bleeding Patterns Are Where Combined Pills Win Clearly

If predictable, regular periods matter to you, combined pills have a clear edge. The estrogen in combined pills stabilizes the uterine lining, producing short, tidy withdrawal bleeds during the placebo week with long, consistent bleeding-free intervals. Progestin-only pill users tend to have more frequent and longer bleeding episodes with shorter, less predictable gaps between them.⁶

In clinical trials, irregular cycles occurred far more often with older progestin-only pills than with combined pills.⁷ One surprising finding, though: progestin-only pills actually produced fewer spotting days than combined pills.⁶ The issue isn’t spotting so much as unpredictability. You may bleed less often on a progestin-only pill, but you’re less likely to know when it’s coming. For some people that’s a minor annoyance; for others it’s a deal-breaker.

Newer Progestin-Only Pills Are Closing the Gap

The traditional progestin-only pill landscape is changing. A newer formulation containing 4 mg of drospirenone, taken in a 24-days-on/4-days-off cycle, behaves more like a combined pill in some respects. Its effectiveness (measured by Pearl Index) is comparable to typical combined pills, and its bleeding profile is substantially better than older progestin-only pills, with higher rates of scheduled bleedings and much lower rates of unscheduled bleeding and spotting.⁸ It still isn’t identical to a combined pill in terms of cycle regularity — amenorrhea (no bleeding at all) is more common, and scheduled bleeds are less frequent — but it represents a genuine improvement over the older progestin-only options.

From a clotting standpoint, the drospirenone-only pill appears reassuring. Studies of its effects on coagulation markers showed no worsening and even some favorable shifts, including increases in protein S and antithrombin III, both of which help prevent clotting.⁹ The drospirenone-only pill also has a 24-hour dosing window rather than the strict three-hour window of older progestin-only pills, making it more forgiving in daily use. If the traditional progestin-only pill sounded right for your health profile but the bleeding unpredictability put you off, this newer formulation is worth asking about.

Acne and Skin Effects Favor Combined Pills

Combined pills have a well-established role in managing acne and excess hair growth. The estrogen component raises a protein called sex hormone-binding globulin, which binds up free testosterone and reduces its effects on skin and hair follicles. Progestin-only methods don’t do this, and some progestins are mildly androgenic, meaning they can worsen acne or oily skin in susceptible people.

A trial directly comparing levonorgestrel-only pills to a combined pill containing levonorgestrel and ethinylestradiol found that the combined pill produced significantly greater reductions in free testosterone levels and acne severity after six months.¹⁰ For excess hair growth, the combined pill also performed better, though the difference was not as pronounced. If clearer skin is a priority alongside contraception, combined pills are the stronger choice.

Mood Effects Are Complicated for Both

The relationship between hormonal contraception and mood is one of the most debated topics in reproductive medicine, and neither category gets a clean bill of health. A large Danish cohort study found that all forms of hormonal contraception were associated with a modestly higher rate of first-time antidepressant use compared to non-users. Combined oral contraceptive users had a relative risk of about 1.2, while progestin-only pill users had a slightly higher relative risk of about 1.3.¹¹ Non-oral methods showed larger associations: the injectable (DMPA) was linked to the highest risk, with a relative risk of about 2.7, while the implant and patch also showed elevated rates.

The picture gets murkier when you look at the progestogen type. Some research suggests that the mood effects relate to the specific progestogen in the pill rather than whether estrogen is also present.¹² Older combined formulations with certain progestogens may be worse for mood than newer ones. The honest summary is that mood effects are real but highly individual. Switching from combined to progestin-only (or vice versa) sometimes helps, but it’s not a guaranteed fix because the progestogen itself matters as much as whether estrogen is in the mix.

Breast Cancer Risk

For a long time, progestin-only methods were assumed to be safer than combined pills when it came to breast cancer, on the theory that estrogen was the main driver of risk. Recent research has challenged that assumption. A large 2025 study found that both combined and progestin-only contraceptives were associated with increased breast cancer risk, with progestin-only methods actually carrying a slightly higher hazard ratio than combined methods.¹³ A UK nested case-control study reached a broadly similar conclusion: current or recent use of progestogen-only contraceptives was associated with a slight increase in breast cancer risk that was comparable in size to the risk from combined methods.¹⁴

The absolute numbers still put this in perspective. The 2025 study estimated roughly 13 additional breast cancer cases per 100,000 person-years of use across all hormonal contraceptive types.¹³ Because underlying breast cancer risk rises with age, the absolute extra risk is smaller for younger users and larger for older ones. Meanwhile, long-acting progestin-based methods like the hormonal IUD and implant appear to reduce endometrial and ovarian cancer risk, similar to the protective effect seen with combined pills.¹⁵ So neither category is clearly “safer” from a cancer standpoint; the picture varies by cancer type.

Bone Health and the DMPA Question

Most hormonal contraceptives have little meaningful effect on bone density. Combined pills and progestin-only implants don’t appear to cause bone loss.¹⁶ The exception, again, is the injectable DMPA. Because DMPA strongly suppresses estrogen production, it can cause measurable bone loss, particularly in adolescents and younger users. A prospective study in adolescents found that bone density decreased about 1.5% after one year of DMPA use and about 3.1% after two years, while users of implants and combined pills showed the normal bone gains expected during adolescence.¹⁷

In older reproductive-age users (roughly 40 to 49), one study found no significant difference in bone density among users of DMPA, another injectable, or combined pills.¹⁸ The concern with DMPA and bone is most pressing during the teenage years and early twenties, when bones are still actively building density. If you’re considering a progestin-only method and bone health worries you, it’s the injectable specifically, not the category as a whole, that warrants caution.

Breastfeeding and Postpartum Use

Progestin-only contraception has been the default recommendation during breastfeeding for years, based on the concern that estrogen might reduce milk supply. A scoping review of guidelines and literature confirmed that progestin-only methods continue to demonstrate safety for breastfeeding, while low-quality evidence supports the worry about combined methods reducing milk production.¹⁹

The evidence is less clear-cut than the recommendations suggest, though. One double-blind randomized trial found no differences in breastfeeding continuation rates, infant growth, or contraceptive continuation between progestin-only and combined pill users over an eight-week study period. About 64% of participants in each group were still breastfeeding at eight weeks.²⁰ An older Cochrane trial similarly found no significant differences in milk volume, infant growth, or milk composition when comparing progestin-only contraceptives to placebo early postpartum.²¹ The clinical consensus still favors progestin-only methods during breastfeeding as a precaution, but the actual trial data comparing them head-to-head is thin and hasn’t shown the dramatic milk-supply effects many people fear.

Managing Endometriosis and Heavy Periods

Both categories are used therapeutically beyond contraception, particularly for endometriosis and heavy menstrual bleeding. A systematic review and meta-analysis comparing progestogens to combined pills for endometriosis found no significant differences in pelvic pain, painful periods, pain during sex, or psychological health, and similar side effect profiles.²² That said, when researchers looked at which group was more likely to stop treatment due to side effects, combined hormonal contraceptives were significantly more likely to be discontinued, particularly because of persistent pain, weight gain, and spotting.²³

For heavy menstrual bleeding, a systematic review found that both progestin-only and combined pills were equally effective at reducing blood loss and improving hemoglobin levels, with nearly identical average hemoglobin improvements. Combined pills were linked to more nausea, headaches, and weight gain, while progestin-only pills had a more favorable side-effect profile.²⁴ So when the goal is managing a condition rather than simply preventing pregnancy, progestin-only methods often match combined pills on effectiveness while being somewhat easier to tolerate.

Return to Fertility After Stopping

A persistent worry about hormonal contraception is that it might delay the ability to get pregnant after discontinuation. The evidence suggests the delay is real but temporary for all hormonal methods, and by one year out, the differences between categories essentially vanish. A narrative review of the evidence found that while there is a short-term delay in return to fertility after progestin-only methods, pregnancy rates at one year of discontinuation are similar to those seen after stopping any other contraceptive method.²⁵ Hormonal IUD users tend to return to fertility fastest, while injectable users take the longest, but the one-year pregnancy rates converge.

A separate study of over 2,000 people stopping oral contraceptives found that about 21% became pregnant in the first cycle after stopping, and about 79% were pregnant within a year. The type of progestin in the pill, the dose of estrogen, and the duration of use had no major influence on those rates.²⁶ If you’re choosing between combined and progestin-only with future fertility in mind, neither category puts you at a lasting disadvantage.

Drug Interactions Are Less Studied for Progestin-Only Methods

Both combined and progestin-only pills can interact with other medications, particularly drugs that speed up liver metabolism. Certain anti-seizure medications, some HIV treatments, and the antibiotic rifampin can reduce the effectiveness of hormonal contraceptives by breaking down the hormones faster than intended. The catch is that progestin-only pills have been studied much less than combined pills when it comes to these interactions.²⁷ That doesn’t mean progestin-only pills are safer or riskier in this respect; it means the evidence is thinner, and your pharmacist or prescriber may need to be more cautious when evaluating interactions.

Environmental Footprint of Contraceptive Hormones

One dimension of the combined-versus-progestin-only question that rarely comes up in a clinic visit is the environmental one. Synthetic hormones from contraceptives are excreted and end up in wastewater. Ethinylestradiol, the estrogen in most combined pills, has received the most scrutiny because of its potency in disrupting aquatic ecosystems, and its concentrations in treated wastewater effluent regularly exceed the levels thought to be safe for aquatic species.²⁸

Progestins aren’t innocent bystanders, though. Levonorgestrel, one of the most widely used progestins, is also detectable in wastewater at concentrations that may pose a risk of endocrine-related effects in fish. Laboratory studies exposing fathead minnows to environmentally relevant concentrations of both levonorgestrel and ethinylestradiol found that each chemical inhibited egg production, and the mixture produced effects at even lower doses.²⁹ Switching from a combined pill to a progestin-only pill eliminates the ethinylestradiol contribution, but it doesn’t eliminate the progestin’s environmental presence. This isn’t likely to drive anyone’s contraceptive decision, but it’s worth knowing that both categories leave a chemical trace in waterways.

1
PubMed. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen
2
PubMed Central. Progestin-only contraception and thrombosis: an updated systematic review
3
PubMed Central. Contraindications to progestin-only oral contraceptive pills among reproductive aged women
4
PubMed. Estrogen-free oral hormonal contraception: benefits of the progestin-only pill
5
Cochrane Library. Progestin-only pills for contraception
6
Contraception. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception
7
Cochrane Database of Systematic Reviews. Progestin‐only pills: contraception vs. combined oral contraceptives
8
PubMed. Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception
9
PubMed. A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns
10
PubMed. Levonorgestrel vs combined oral contraceptive pills in treatment of female acne and hirsutism
11
JAMA Psychiatry. Association of Hormonal Contraception With Depression
12
PubMed Central. Hormonal contraception and mood disorders
13
JAMA Oncology. Hormonal Contraceptive Formulations and Breast Cancer Risk in Adolescents and Premenopausal Women
14
PLOS Medicine. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case–control study and meta-analysis
15
JNCI: Journal of the National Cancer Institute. Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers
16
PubMed. Impact of combined and progestogen-only contraceptives on bone mineral density
17
PubMed. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives
18
PubMed. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception
19
PubMed. Breastfeeding and Hormonal Contraception: A Scoping Review of Clinical Guidelines, Professional Association Recommendations, and the Literature
20
PubMed Central. Effect of progestin vs. combined oral contraceptive pills on lactation: A double-blind randomized controlled trial
21
Cochrane Database of Systematic Reviews. Hormonal contraception for women during lactation
22
PubMed. Clinical effectiveness of progestogens compared to combined oral contraceptive pills in the treatment of endometriosis: A systematic review and meta-analysis
23
PubMed Central. Tolerability of endometriosis medical treatment: a comparison between combined hormonal contraceptives and progestins
24
PubMed Central. Combined Oral Contraceptive Pills Versus Progestin-Only Pills for Heavy Menstrual Bleeding: A Systematic Review
25
BMJ. Return to fertility following the discontinuation of progestin-only contraceptives: a narrative review of the evidence
26
Obstetrics & Gynecology. Rate of Pregnancy After Using Drospirenone and Other Progestin-Containing Oral Contraceptives
27
PubMed. Drug-drug interactions between psychotropic medications and oral contraceptives
28
PubMed. Concentrations of levonorgestrel and ethinylestradiol in wastewater effluents: Is the progestin also cause for concern?
29
PubMed. From single chemicals to mixtures–reproductive effects of levonorgestrel and ethinylestradiol on the fathead minnow